134 related articles for article (PubMed ID: 37664531)
1. IgG4-related disease and prostate cancer: A case report and review of the literature.
Zekhnini A; Taussky D; Lattouf JB; Koenig M
Urol Case Rep; 2023 Sep; 50():102538. PubMed ID: 37664531
[TBL] [Abstract][Full Text] [Related]
2. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
3. Incidental finding of metastatic prostatic adenocarcinoma of cerebellopontine angle presenting as acoustic neuroma: A case report and review of literature.
Ma QF; Ou CY; Wang QH; Wang YN
Int J Surg Case Rep; 2022 Sep; 98():107493. PubMed ID: 35969908
[TBL] [Abstract][Full Text] [Related]
4. Favorable outcome of Epstein-Barr virus-associated B-cell lymphoproliferative disorder complicated by immunoglobulin G4-related disease treated with rituximab-based therapy: a case report.
Ueda K; Ikeda K; Ogawa K; Sukegawa M; Sano T; Kimura S; Suzuki O; Hashimoto Y; Takeishi Y
J Med Case Rep; 2016 Aug; 10(1):236. PubMed ID: 27557810
[TBL] [Abstract][Full Text] [Related]
5. Symptomatic IgG4-Related Prostatitis Simultaneously Diagnosed with Aggressive Prostate Cancer.
Ezaki T; Akatsuka S; Sanjo T; Masuda T
Case Rep Urol; 2020; 2020():6045328. PubMed ID: 32190400
[TBL] [Abstract][Full Text] [Related]
6. "Just Another Statistic".
Machtay M; Glatstein E
Oncologist; 1998; 3(3):III-IV. PubMed ID: 10388105
[TBL] [Abstract][Full Text] [Related]
7. A Rare Case of Castrate-Resistant Prostate Adenocarcinoma with a Unilateral Testicular Metastasis Mimicking a Primary Testicular Tumour.
Hong JH; Nindra U; Nguyen R; Gassner P; Balakrishnar B; Rutland T
Case Rep Oncol; 2022; 15(3):1055-1062. PubMed ID: 36605230
[TBL] [Abstract][Full Text] [Related]
8. Should the denosumab metastasis prevention trial change practice for men with nonmetastatic prostate cancer?
Saylor PJ; Michaelson MD
Oncologist; 2012; 17(2):288-90. PubMed ID: 22267850
[TBL] [Abstract][Full Text] [Related]
9. Rituximab was used to treat recurrent IgG4-related hypophysitis with ophthalmopathy as the initial presentation: A case report and literature review.
Gu WJ; Zhang Q; Zhu J; Li J; Wei SH; Mu YM
Medicine (Baltimore); 2017 Jun; 96(24):e6934. PubMed ID: 28614220
[TBL] [Abstract][Full Text] [Related]
10. IgG4-Related Autoimmune Prostatitis: Is It an Unusual or Underdiagnosed Manifestation of IgG4-Related Disease?
Bourlon MT; Sánchez-Ávila M; Chablé-Montero F; Arceo-Olaiz R
Case Rep Urol; 2013; 2013():295472. PubMed ID: 24349818
[TBL] [Abstract][Full Text] [Related]
11. IgG4-related prostatitis manifesting as urinary obstruction in a 28-year-old male.
Jazdarehee A; Ahrari A; Bowie D; Chang SD; Tran H; Jamal S; Chen LYC; Tran KC
BMC Urol; 2022 Mar; 22(1):35. PubMed ID: 35277143
[TBL] [Abstract][Full Text] [Related]
12. Rituximab for retroperitoneal fibrosis due to IgG4-related disease: A case report and literature review.
Almeqdadi M; Al-Dulaimi M; Perepletchikov A; Tomera K; Jaber BL
Clin Nephrol Case Stud; 2018; 6():4-10. PubMed ID: 29845002
[TBL] [Abstract][Full Text] [Related]
13. Scrotal Skin Metastases Revealing a Prostatic Adenocarcinoma.
Ziani I; Makhoukh ZEBE; Ibrahimi A; Bellouki O; Benahmed J; Laraqui Y; Zouidia F; Sayegh HE; Benslimane L; Nouini Y
Case Rep Urol; 2020; 2020():8826627. PubMed ID: 32963877
[TBL] [Abstract][Full Text] [Related]
14.
Petersen LJ; Nielsen JB; Dettmann K; Fisker RV; Haberkorn U; Stenholt L; Zacho HD
Mol Clin Oncol; 2017 Jul; 7(1):67-72. PubMed ID: 28685078
[TBL] [Abstract][Full Text] [Related]
15. Colon cancer and IgG4-related disease with orbital inflammation and bilateral optic perineuritis: A case report.
Lemaitre S; Esquerda GM; Guardiola AC; Agustin JT; Sanda N; González-Candial M
Medicine (Baltimore); 2018 Sep; 97(39):e12197. PubMed ID: 30278491
[TBL] [Abstract][Full Text] [Related]
16. Steroid-responsive IgG4-related disease with isolated prostatic involvement: An unusual presentation with elevated serum PSA.
Jain V; Pandey PK; Bihari C
Indian J Urol; 2016; 32(2):166-8. PubMed ID: 27127365
[TBL] [Abstract][Full Text] [Related]
17. Complete remission of central nervous system manifestations of IgG4-related disease with rituximab - a case report.
Sihvonen AJ; Laakso SM; Tynninen O; Saaren-Seppälä H; Löfberg M
Ther Adv Neurol Disord; 2023; 16():17562864231186091. PubMed ID: 37483642
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Significance of PSA, Gleason Score, Bone Metastases in Patients with Metastatic Prostate Cancer Under Palliative Androgen Deprivation Treatment.
Abu-Hamar Ael H; Gameel TA
J Egypt Natl Canc Inst; 2009 Sep; 21(3):229-36. PubMed ID: 21132033
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Value of the Intermediate-risk Feature in Men with Favorable Intermediate-risk Prostate Cancer: Implications for Active Surveillance.
Sherer MV; Leonard AJ; Nelson TJ; Courtney PT; Guram K; Rodrigues De Moraes G; Javier-Desloges J; Kane C; McKay RR; Rose BS; Bagrodia A
Eur Urol Open Sci; 2023 Apr; 50():61-67. PubMed ID: 37101776
[TBL] [Abstract][Full Text] [Related]
20. Is there a role for ¹¹C-choline PET/CT in the early detection of metastatic disease in surgically treated prostate cancer patients with a mild PSA increase <1.5 ng/ml?
Castellucci P; Fuccio C; Rubello D; Schiavina R; Santi I; Nanni C; Allegri V; Montini GC; Ambrosini V; Boschi S; Martorana G; Marzola MC; Fanti S
Eur J Nucl Med Mol Imaging; 2011 Jan; 38(1):55-63. PubMed ID: 20848281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
